Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy
Karen L Hardinger, Daniel Sunderland, Jennifer A Wiederrich Division of Pharmacy Practice and Administration, School of Pharmacy, University of Missouri–Kansas City, Kansas City, MO, USA Background: Belatacept is a novel immunosuppressive therapy designed to improve clinical outcomes assoc...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | International Journal of Nephrology and Renovascular Disease |
| Subjects: | |
| Online Access: | https://www.dovepress.com/belatacept-for-the-prophylaxis-of-organ-rejection-in-kidney-transplant-peer-reviewed-article-IJNRD |